These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


656 related items for PubMed ID: 25421656

  • 21. Epigenetic Silencing of the Putative Tumor Suppressor Gene GLDC (Glycine Dehydrogenase) in Gastric Carcinoma.
    Min HL, Kim J, Kim WH, Jang BG, Kim MA.
    Anticancer Res; 2016 Jan; 36(1):179-87. PubMed ID: 26722042
    [Abstract] [Full Text] [Related]

  • 22. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y, Xu Z, Li B, Zhang Z, Luo H, Wang Y, Lu Z, Wu X.
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [Abstract] [Full Text] [Related]

  • 23. Epigenetic alterations in cancer.
    Ilango S, Paital B, Jayachandran P, Padma PR, Nirmaladevi R.
    Front Biosci (Landmark Ed); 2020 Mar 01; 25(6):1058-1109. PubMed ID: 32114424
    [Abstract] [Full Text] [Related]

  • 24. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
    Gerhauser C.
    Top Curr Chem; 2013 Mar 01; 329():73-132. PubMed ID: 22955508
    [Abstract] [Full Text] [Related]

  • 25. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
    Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y.
    Carcinogenesis; 2010 Dec 01; 31(12):2066-73. PubMed ID: 20924086
    [Abstract] [Full Text] [Related]

  • 26. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
    Puneet, Kazmi HR, Kumari S, Tiwari S, Khanna A, Narayan G.
    Pathol Oncol Res; 2018 Oct 01; 24(4):757-770. PubMed ID: 29552712
    [Abstract] [Full Text] [Related]

  • 27. Epigenetic effects of nano-sized materials.
    Stoccoro A, Karlsson HL, Coppedè F, Migliore L.
    Toxicology; 2013 Nov 08; 313(1):3-14. PubMed ID: 23238276
    [Abstract] [Full Text] [Related]

  • 28. Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.
    Shinjo K, Kondo Y.
    Methods Mol Biol; 2012 Nov 08; 863():221-39. PubMed ID: 22359296
    [Abstract] [Full Text] [Related]

  • 29. Epigenetic alterations in gastric carcinogenesis.
    Choi IS, Wu TT.
    Cell Res; 2005 Apr 08; 15(4):247-54. PubMed ID: 15857579
    [Abstract] [Full Text] [Related]

  • 30. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG, Shariat SF.
    Eur Urol; 2011 Oct 08; 60(4):753-66. PubMed ID: 21719191
    [Abstract] [Full Text] [Related]

  • 31. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR, Roberts JL, Fu VX, Jarrard DF.
    J Urol; 2007 Mar 08; 177(3):822-31. PubMed ID: 17296351
    [Abstract] [Full Text] [Related]

  • 32. [Epigenetic mechanism of cardiac differentiation of stem cells].
    Zhu H, Liu Y, Zhang Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec 08; 36(12):1217-21. PubMed ID: 22246356
    [Abstract] [Full Text] [Related]

  • 33. Epigenetics and miRNAs in human cancer.
    Fabbri M, Calin GA.
    Adv Genet; 2010 Dec 08; 70():87-99. PubMed ID: 20920746
    [Abstract] [Full Text] [Related]

  • 34. Cancer epigenetics: an introduction.
    Kanwal R, Gupta K, Gupta S.
    Methods Mol Biol; 2015 Dec 08; 1238():3-25. PubMed ID: 25421652
    [Abstract] [Full Text] [Related]

  • 35. Epigenetics: a new link between nutrition and cancer.
    Supic G, Jagodic M, Magic Z.
    Nutr Cancer; 2013 Dec 08; 65(6):781-92. PubMed ID: 23909721
    [Abstract] [Full Text] [Related]

  • 36. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis.
    Shen J, Xiao Z, Wu WK, Wang MH, To KF, Chen Y, Yang W, Li MS, Shin VY, Tong JH, Kang W, Zhang L, Li M, Wang L, Lu L, Chan RL, Wong SH, Yu J, Chan MT, Chan FK, Sung JJ, Cheng AS, Cho CH.
    Cancer Res; 2015 Feb 15; 75(4):754-65. PubMed ID: 25503559
    [Abstract] [Full Text] [Related]

  • 37. Epigenetic regulation of microRNAs in gastric cancer.
    Ma J, Hong L, Chen Z, Nie Y, Fan D.
    Dig Dis Sci; 2014 Apr 15; 59(4):716-23. PubMed ID: 24248419
    [Abstract] [Full Text] [Related]

  • 38. Role of epigenetic modifications in luminal breast cancer.
    Abdel-Hafiz HA, Horwitz KB.
    Epigenomics; 2015 Aug 15; 7(5):847-62. PubMed ID: 25689414
    [Abstract] [Full Text] [Related]

  • 39. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells.
    Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y, Hibi T.
    Oncogene; 2009 Jul 30; 28(30):2738-44. PubMed ID: 19503096
    [Abstract] [Full Text] [Related]

  • 40. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R.
    Drug Dev Res; 2014 Sep 30; 75(6):348-65. PubMed ID: 25195579
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 33.